Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-15 | 1432.0 | 60 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-15 | 1773.5 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-15 | 1872.0 | 52 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-15 | 1533.0 | 52 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-15 | 1545.0 | 66 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-15 | 1382.0 | 53 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 581.0 | 64 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 598.0 | 31 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 669.5 | 54 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 558.0 | 52 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 552.0 | 61 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 629.0 | 58 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 525.5 | 52 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 516.0 | 44 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1329.0 | 53 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1676.0 | 37 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1215.0 | 60 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1432.0 | 55 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1538.0 | 43 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1536.0 | 42 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1408.0 | 40 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-15 | 1258.5 | 60 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 479.0 | 53 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 525.0 | 56 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 519.0 | 55 |